期刊文献+

组蛋白甲基转移酶EZH2在宫颈癌中的研究进展 被引量:1

Research Progress of Histone Methyltransferase EZH2 in Cervical Cancer
下载PDF
导出
摘要 果蝇zeste基因增强子同源物2(enhancer of zeste homolog 2,EZH2)是一种组蛋白赖氨酸甲基转移酶(histone lysine methyltransferase,HKMT)。EZH2主要通过调控组蛋白H3第27位赖氨酸(H3K27)甲基化修饰参与肿瘤的发生、发展等一系列恶性生物学行为,在表观遗传修饰过程中发挥重要作用。研究显示EZH2在宫颈癌中过表达,并且与患者的不良预后密切相关。EZH2可以促进宫颈癌的增殖、迁移、侵袭、血管生成、耐药以及免疫逃逸等行为。对EZH2的深入研究有望为宫颈癌提供新的分子靶点,从而有助于宫颈癌的早期诊断、预后评估和靶向治疗。 Enhancer of zeste homolog 2(EZH2)is a kind of histone lysine methyltransferase(HKMT).It participates in the malignant behavior of tumorigenesis and development mainly through regulating the methylation modification of H3K27,which plays an important role in epigenetic modification.The researches show that EZH2 is highly expressed in cervical cancer and it is closely related to the poor prognosis of patients.EZH2 takes part in the proliferation,migration,invasion,angiogenesis,drug resistance and immune escape of cervical cancer.The in-depth study of EZH2 is expected to provide a new therapeutic target for cervical cancer,so as to contribute to the early diagnosis,prognosis evaluation and targeted treatment of cervical cancer.
作者 王昭娣 王悦(审校) WANG Zhao-di;WANG Yue(Department of Obstetrics and Gynecology,Henan University People′s Hospital,Henan Provincial People′s Hospital,Zhengzhou 450003,China)
出处 《国际妇产科学杂志》 CAS 2022年第3期291-295,共5页 Journal of International Obstetrics and Gynecology
基金 河南省省直医疗机构医疗服务能力提升工程建设项目(豫卫医[2017]66号) 郑州市2020年度科技惠民计划项目(2020KJHM0020)。
关键词 Zeste同源蛋白2增强子 宫颈肿瘤 甲基化 细胞增殖 细胞凋亡 Enhancer of zeste homolog 2 protein Uterine cervical neoplasms Methylation Cell proliferation Apoptosis
  • 相关文献

参考文献10

二级参考文献49

  • 1Yan Xin,Xiao Ling Li,Yan Ping Wang,Su Min Zhang,Hua Chuan Zheng,Dong Ying Wu,Yin Chang Zhang The Fourth Laboratory of Cancer Institute, China Medical University, Shenyang 110001, Liaoning Province, China.Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas[J].World Journal of Gastroenterology,2001,7(1):53-59. 被引量:39
  • 2彭燕,陈海滨,苏中静,陈玲,张锦,许丽艳.EZH2蛋白在食管癌组织中的表达[J].解剖学报,2006,37(6):650-655. 被引量:6
  • 3JEMAL A, BRAY F, CENTER MM, et al. Global cancer sta- tisticsEJ~. CA Cancer J Clin, 2011, 61(2)~6990.
  • 4KHAN SN, JANKOWSKA AM, MAHFOUZ R, et al. Multi- ple mechanisms deregulate EZH2 and histone H3 lysine 27 epi- genetic changes in myeloid malignancies[J]. Leukemia, 2013, 27(6) :1301-1309.
  • 5HIROHITO Y, MIEN-CHIE H. Regulation and role of EZH2 in cancer[J]. Cancer Res Treat, 2014, 46(3):209-222.
  • 6ALIMOVA I, VENKATARAMAN S, HARRIS P, et al. Tar- geting the enhancer of zeste homologue 2 in medulloblastoma [J],IntJ Cancer, 2012, 131(8) :1800-1809.
  • 7KEMP CD, RAO M, XI S, et al. Polycomb repressor complex- 2 is a novel target for mesothelioma therapy[J]. Clin Cancer Res, 2012, 18(1)~77-90.
  • 8KNUTSON SK, KAWANO S, MINOSHIMA Y, et al. Selec- tive inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma E J~. Mol Cancer Ther, 2014, 13(4) :842-854.
  • 9GUARINO M. Epithelial mesenchymal transition and tumor inva- sionEJ~. Int J Biochen Cell Bio, 2007, 39(12) :2153-2160.
  • 10KRISHNAMACHARY B, ZAGZAG D, NAGASAWA H, et al. Hypoxia-inducible factor-l-dependent repression of E. cadherin in yon Hippel-Lindau tumor suppressor-null renal cell carcinoma medi-ated by TCF3, ZFHZIA, and ZFHZIB[-J~. Cancer Res, 2006, 66 (5) :2725-2731.

共引文献31

同被引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部